| 发明名称 |
Inhibitors of the CD95 signaling pathway for treatment of MDS |
| 摘要 |
The present invention relates to inhibitors of the CD95 signaling pathway for the use in the treatment of Myelodysplastic Syndrom (MDS) wherein the MDS is selected from the IPSS low risk MDS subgroup and/or the IPSS intermediate-1 (int-1 ) risk MDS subgroup as well as a method for the diagnosis of MDS. |
| 申请公布号 |
AU2013291981(A1) |
申请公布日期 |
2015.01.22 |
| 申请号 |
AU20130291981 |
申请日期 |
2013.07.18 |
| 申请人 |
APOGENIX GMBH |
发明人 |
FRICKE, HARALD;FONTENAY, MICHAELA |
| 分类号 |
C07K14/705;A61K38/17;A61K39/395;C07K16/28;G01N33/569 |
主分类号 |
C07K14/705 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
